Just two months after telegraphing plans to lay off 641 staffers at two of its Massachusetts sites, Takeda is parting ways ...

Inovio has changed its chief commercial officer ahead of the planned launch of its first DNA medicine, putting Merck veteran ...

After more than a decade with no treatment advances for chronic obstructive pulmonary disease (COPD), two have been approved ...

The world’s first injectable immune checkpoint inhibitor likely won’t make it to the U.S. anytime soon after the ...

With four contract modifications totaling more than $250 million, the government is leveling up its agreements with long-time ...

As Korean CDMO giant Samsung Biologics continues to ink production pacts around the globe, the company has added another ...

Even as the BIOSECURE Act charts an uncertain path through the legislative process, the draft bill has already seriously ...

Marketing and communications company CG Life recently strengthened the public relations side of the business by acquiring ...